- (Anticancer Research 33, 10 (4483)). Anticancer research. 2013 Erratum
- Comprehensive head and neck radiotherapy dose-volume constraints do not apply to smaller volumes. Anticancer research. 2013 Academic Article GET IT
Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a phase 2 multi-institutional trial.
The Lancet. Oncology.
Times cited: 100
High-dose-rate intraoperative radiation therapy (HDR-IORT) for retroperitoneal sarcomas.
International Journal of Radiation Oncology Biology Physics.
Times cited: 124
Radiotherapy in the management of plasma cell tumors.
Times cited: 77
30 Gy may be an adequate dose in patients with anal cancer treated with excisional biopsy followed by combined-modality therapy.
Journal of Surgical Oncology.
Times cited: 33